Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

HealthLynked (HLYK) Long-Term Debt Issuances (2016 - 2025)

HealthLynked (HLYK) has disclosed Long-Term Debt Issuances for 9 consecutive years, with -$280000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Long-Term Debt Issuances fell 166.67% to -$280000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.9 million, a 554.76% decrease, with the full-year FY2024 number at $335000.0, down 73.89% from a year prior.
  • Long-Term Debt Issuances was -$280000.0 for Q3 2025 at HealthLynked, down from $535000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $597999.0 in Q4 2023 to a low of -$2.3 million in Q4 2024.
  • A 4-year average of -$27854.2 and a median of $225875.0 in 2023 define the central range for Long-Term Debt Issuances.
  • Peak YoY movement for Long-Term Debt Issuances: soared 327.81% in 2023, then plummeted 684.95% in 2024.
  • HealthLynked's Long-Term Debt Issuances stood at -$262500.0 in 2022, then surged by 327.81% to $597999.0 in 2023, then crashed by 491.31% to -$2.3 million in 2024, then skyrocketed by 88.03% to -$280000.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Long-Term Debt Issuances are -$280000.0 (Q3 2025), $535000.0 (Q2 2025), and $175000.0 (Q1 2025).